ABSTRACT
MicroRNAs (miRNAs) control the expression of protein-coding genes in normal hematopoietic cells and, consequently, aberrant expression may contribute to leukemogenesis. To identify miRNAs relevant to pediatric acute lymphoblastic leukemia (ALL), we cloned 105 known and 8 new miRNA genes expressed in patients' leukemia cells. Instead of known miRNA genes, new miRNA genes were not evolutionarily conserved. Quantification of 19 selected miRNA genes revealed an aberrant expression in ALL as compared with normal CD34+ cells (P Subject(s)
MicroRNAs/genetics
, Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics
, RNA, Neoplasm/genetics
, Cloning, Molecular
, Gene Expression Regulation, Neoplastic
, Humans
, Infant
, Infant, Newborn
, MicroRNAs/isolation & purification
, Myeloid-Lymphoid Leukemia Protein/genetics
, RNA, Neoplasm/isolation & purification
ABSTRACT
Delayed hypersensitivity to antigens derived from four EBV-related (KHLY 28, Raji, F265 and NC37) and one EBV-unrelated (Molt) T-lymphoid cell lines and to standard antigens (Trichophyton, Candida albicans and streptokinase/streptodornase) was measured in 104 NPC patients and 24 patients with other cancers. Of the NPC patients with non-disseminated disease, 55/86 (63.2%) had a positive skin reaction to HKLY 28 extract, compared with only 1/18 (5.6%) OC patients with non-disseminated disease. The frequencies of these NPC patients with positive skin reactions to the other cell-line extracts were significantly lower (1.7-5.4%). From the preliminary results of a longitudinal study, skin testing with this particular crude membrane extract from HKLY 28 cells appears to be of little practical value in monitoring the clinical evolution of NPC, although a significant association between clinical evolution and certain patterns of skin reactivity response to the extract was found in about two-thirds of the cases analysed.
Subject(s)
Antigens, Viral/immunology , Carcinoma/immunology , Herpesvirus 4, Human/immunology , Immunity, Cellular , Nasopharyngeal Neoplasms/immunology , Antigens/immunology , Carcinoma/radiotherapy , China , Humans , Hypersensitivity, Delayed/immunology , Immunity, Cellular/radiation effects , Longitudinal Studies , Nasopharyngeal Neoplasms/radiotherapy , Neoplasms/immunology , Skin TestsABSTRACT
New data are presented concerning the relationship between NPC and HLA antigens among Chinese. When attention is confined to newly diagnosed cases, it can be shown that, apart from the increased risk associated with the joint occurrence of A2 and B-Sin 2, there is also an increased risk associated with BW17 and a decrease in risk associated with A11. Among long-term survivors, however, BW17 is appreciably decreased, whereas A2 in the absence of B-Sin 2 or BW17 is increased. Among Malays, a non-Chinese group, there is an excess among NPC patients of a locus A blank, a blank which is probably associated with the AW19 complex.
Subject(s)
Carcinoma/immunology , HLA Antigens/analysis , Nasopharyngeal Neoplasms/immunology , Carcinoma/etiology , Carcinoma/genetics , Carcinoma/mortality , China , Chromosome Mapping , Gene Frequency , Genes , HLA Antigens/genetics , Humans , Malaysia , Nasopharyngeal Neoplasms/etiology , Nasopharyngeal Neoplasms/genetics , Nasopharyngeal Neoplasms/mortality , PhenotypeABSTRACT
Histocompatibility locus A typing of 43 Malaysian Chinese and 51 Hong Kong Chinese patients with nasopharyngeal carcinoma (NPC) confirmed the association between the occurrence of A2-Sin 2 and the increased risk for NPC that was previously demonstrated in Singapore Chinese. The results support the previous interpretation that the histocompatibility locus A genotype of importance in NPC predisposition is the A2-Sin 2 haplotype. The histocompatibility locus A-linked, genetically determined NPC risk is common to Asian Chinese from at least three geographic locations.
Subject(s)
Asian People , HLA Antigens , Nasopharyngeal Neoplasms/immunology , China/ethnology , Hong Kong , Humans , Malaysia , Nasopharyngeal Neoplasms/genetics , Phenotype , Risk , SingaporeSubject(s)
Antibodies, Viral , Carcinoma, Squamous Cell/immunology , Herpesvirus 4, Human/immunology , Nasopharyngeal Neoplasms/immunology , Antibodies, Viral/analysis , Carcinoma, Squamous Cell/therapy , Follow-Up Studies , Humans , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Nasopharyngeal Neoplasms/therapy , Neoplasm Metastasis , Neoplasm Recurrence, LocalABSTRACT
The sera of 73 patients with nasopharyngeal carcinoma (NPC), 28 patients with other carcinomas (OC) and 89 healthy subjects (HS) were tested for IgG and IgA antibodies to Epstein-Barr virus (EBV) viral capsid antigen (VCA). The majority of the NPC sera had IgG titres of 160 or above, whereas the majority of the other sera had titres below 160. For IgA reactivity to EBV-VCA, 68 of 73 (93-2%) NPC sera had titres of greater than or equal to 10. In contrast, only 6 of 28 (21-4%) OC sera and none of the HS sera had such titres. The mean serum concentrations of IgG, IgA, IgM and C3' were also determined in 55 NPC and 20 OC patients and 18 HS. They were all significantly higher in the NPC sera than in the HS. Although the concentrations of IgG and C3' were not significantly different in the two carcinoma groups, the concentrations of IgA and IgM were significantly higher in the NPC group than in OC. These findings appear to reflect the intensity of EBV-specific antigenic stimulation in NPC, and the EBV-specific serum IgA reactivity may be a sueful aid to the diagnosis of NPC, especially in cases with an occult primary tumour. It may be also of value as a screening test in people at high risk.
Subject(s)
Antibodies, Viral/analysis , Herpesvirus 4, Human/immunology , Immunoglobulin A , Immunoglobulin G , Nasopharyngeal Neoplasms/immunology , Antibody Specificity , HumansABSTRACT
The general cell-mediated immunological reactivity of patients with acute leukemia has been found to be intact, although it may be depressed by extensive disease or by chemotherapy. Patients with acute leukemia also have cellular immune reactivity against tumor associated antigens, as measured by skin tests for delayed hypersensitivity, lymphocyte stimulation, and 51Cr release cytotoxicity. Skin reactions to autologous and allogeneic crude membrane extracts of blast cells correlated with disease state, positive in many patients in remission and negative in most patients in relapse. Extracts of human lymphoid tissue culture cell lines derived from lymphomas or leukemia also gave positive reactions in patients with acute leukemia, and also in patients with lymphoma and nasopharyngeal carcinoma. The antigens detected in the skin tests with the lymphoid cell lines appear to be different from those associated with Epstein-Barr virus (EBV) and from those detected in the 51Cr release assay. Evidence is presented which suggests a complex variety of antigens on blast cells and on the cell lines. Although leukemia associated antigens were also detected by lymphocyte stimulation and by cytotoxicity assays, the results did not correlate with the skin tests nor with each other. The possible use of these assays for monitoring the chemotherapy and immunotherapy of acute leukemia patients is discussed.